Stockscreener 앱 받기
1.4151
9.77%
0.1351
전일 마감가:
$1.28
열려 있는:
$1.31
하루 거래량:
546.79K
Relative Volume:
1.04
시가총액:
$112.07M
수익:
$2.43M
순이익/손실:
$-52.67M
주가수익비율:
-1.1231
EPS:
-1.26
순현금흐름:
$-33.04M
1주 성능:
+1.08%
1개월 성능:
-3.77%
6개월 성능:
+66.04%
1년 성능:
+25.45%
1일 변동 폭
$1.29
$1.4201
1주일 범위
$1.18
$1.4201
52주 변동 폭
$0.6301
$1.633
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
LUCD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.4192 | 112.07M | 2.43M | -52.67M | -33.04M | -1.26 |
|
ABT
Abbott Laboratories
|
126.28 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
97.20 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
370.00 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
93.09 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.76 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
Blue Cross Blue Shield backs esophageal cancer DNA test - Investing.com India
Lucid Diagnostics Secures First Positive Commercial Insurance Coverage Policy for its EsoGuard® Esophageal DNA Test - PR Newswire
Lucid Diagnostics Executes First Concierge Medicine Contract wit - GuruFocus.com
Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Pri - GuruFocus.com
PAVmed CEO to Reveal Growth Strategy and Q4 Results in Upcoming Investor Call - StockTitan
Lucid Diagnostics (NASDAQ:LUCD) Trading Down 14.4% – Here’s Why - Defense World
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025 - BioSpace
Analyzing Embecta (NASDAQ:EMBC) and Lucid Diagnostics (NASDAQ:LUCD) - Defense World
Understanding Lucid Diagnostics Inc (NASDAQ: LUCD)’s Growth Potential - Stocks Register
Midtown company tells investors esophageal pre-cancer screening should be an easier pill to swallow - Crain's New York Business
Lucid Diagnostics secures $15.3 million in stock offering By Investing.com - Investing.com Australia
Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering - GuruFocus.com
Lucid Diagnostics secures $15.3 million in stock offering - Investing.com India
Lucid Diagnostics Raises $15.3 Million in Stock Offering - TipRanks
Lucid Diagnostics secures $15.3 million in stock sale By Investing.com - Investing.com Australia
Lucid Diagnostics Announces $15.3 Million Registered Direct Offering - The Eastern Progress Online
SEC Form 424B5 filed by Lucid Diagnostics Inc. - Quantisnow
Lucid Diagnostics announces registered direct offering - Medical Buyer
Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus.com
Lucid Diagnostics Announces $15.3 Mln Direct Offering - Nasdaq
Lucid Diagnostics ends "at the market" equity offering By Investing.com - Investing.com South Africa
Lucid Diagnostics stock dips on $15.3M share offering - MSN
Lucid Diagnostics secures $15.3 million in stock sale - Investing.com India
Lucid Diagnostics Prices $15.3 Million Direct Offering -March 04, 2025 at 09:03 am EST - Marketscreener.com
Lucid Diagnostics Announces $15.3 Million Direct Offering - TipRanks
Lucid Diagnostics ends "at the market" equity offering - Investing.com India
Lucid Diagnostics to sell 13.94M shares at $1.10 in registered direct offering - TipRanks
Lucid Diagnostics Raises $15.3 Million Through Common Stock Offering at $1.10 Per Share - StockTitan
Can Lucid's Cancer Test Reach Millions More Patients? NIH Invests $8M to Find Out - StockTitan
Renowned Investigators Awarded $8 Million NIH Grant to Study Luc - GuruFocus.com
Lucid Diagnostics meets Nasdaq minimum bid price rule By Investing.com - Investing.com Australia
Lucid Diagnostics Restores Nasdaq Listing Compliance - Nasdaq
Lucid Diagnostics regains compliance with Nasdaq listing requirement - MSN
Lucid Diagnostics meets Nasdaq minimum bid price rule - Investing.com
Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement - PR Newswire
Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health -February 20, 2025 at 08:31 am EST - Marketscreener.com
Lucid Diagnostics secures concierge medicine contract By Investing.com - Investing.com Nigeria
LUCDLucid Diagnostics Inc. Latest Stock News & Market Updates - StockTitan
Lucid Diagnostics secures concierge medicine contract - Investing.com
Lucid Diagnostics Executes First Concierge Medicine Contract with LEAA Health - Nasdaq
PAVmed regains compliance with Nasdaq Capital Market’s CLS - Medical Buyer
PAVMPavmed Latest Stock News & Market Updates - StockTitan
Innovative Tech Company Surges Forward: PAVmed Triumphs in Nasdaq Compliance - Smartphone Magazine
Navigating the High Seas of Market Compliance: PAVmed’s Resilient Return - Mi Valle
PAVmed Triumphs on Nasdaq: A Medical Tech Comeback Story - Jomfruland.net
Critical Victory: PAVmed's Strategic Moves Save Nasdaq StatusFull Details Inside - StockTitan
SI-BONE (NASDAQ:SIBN) vs. Lucid Diagnostics (NASDAQ:LUCD) Head to Head Survey - Defense World
Lucid Diagnostics stock hits 52-week high at $1.5 amid growth optimism - MSN
Lucid Diagnostics (NASDAQ:LUCD) vs. Insulet (NASDAQ:PODD) Head-To-Head Review - Defense World
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.57%
0.83%
자본화:
|
볼륨(24시간):